Translational Science

Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.

Using CRISPR to engineer cell therapies with multiple gene knockouts could be limited by double-strand breaks.

Are there learnings from the COVID-19 pandemic that could be applied to the development and commercialization of advanced therapies?

We reveal The Medicine Maker 2021 Power List!

We find out the story behind the Baylor College of Medicine Center for Space Medicine.

Never before has the industry moved so rapidly to find new treatments and vaccines – but safety and efficacy must remain top priorities.

What lies beyond COVID-19? There are many diseases that could benefit from all the collaborative effort and funding being poured into COVID-19.

NASA ultimately wants to send humans to Mars – and those humans will need medicines.

Drug development needs to move more rapidly, but not at the expense of safety.

Your roundup of the key scientific studies and industry announcements emerging from the pandemic.